TB-500 vs BPC-157: A Researcher's Comparison
By UK Peptide Lab Research Team•28 January 2025•7 min read
Overview
TB-500 and BPC-157 are two of the most widely studied synthetic peptides in preclinical research. Both are frequently examined in the context of tissue repair and inflammatory signalling pathways, and both are commonly used together in laboratory protocols. Despite their overlapping areas of research interest, they are molecularly distinct compounds with different mechanisms and applications.
Researchers can source both BPC-157 and TB-500 from UK Peptide Lab with full batch documentation and UK-based cold chain storage.
Molecular Differences
BPC-157 is a 15 amino acid synthetic peptide derived from a partial sequence of human body protection compound. TB-500 is a synthetic version of Thymosin Beta-4, a naturally occurring 43 amino acid protein found in virtually all human and animal cells. TB-500 specifically corresponds to the actin-binding domain of Thymosin Beta-4, which is understood to be the biologically active region responsible for its effects in cellular research models.
Their molecular weights differ significantly — BPC-157 at approximately 1,419 Da versus TB-500 at approximately 4,963 Da — which influences their behaviour in solution and their interactions with cellular receptors in laboratory models.
Research Applications
BPC-157 research has focused predominantly on gastrointestinal mucosal integrity, tendon and ligament tissue models, angiogenesis, and nitric oxide pathway interactions. It has been examined extensively in rodent models across a wide range of tissue types.
TB-500 research has focused on its role in actin regulation, cell migration, angiogenesis, and inflammation modulation. Thymosin Beta-4 is known to be upregulated in response to tissue injury in biological systems, making TB-500 a useful tool for researchers studying wound healing biology, cardiac tissue models, and neurological repair pathways.
Combined Laboratory Protocols
In laboratory settings, BPC-157 and TB-500 are frequently studied in combination. Their complementary mechanisms — BPC-157's interaction with growth hormone and nitric oxide pathways alongside TB-500's actin regulatory and cell migration properties — make them a commonly used pairing in preclinical tissue research models. Researchers studying repair signalling pathways often use both compounds to examine potential synergistic interactions at the cellular level.
Storage and Handling
Both peptides are supplied as lyophilised powders. Store at -20°C long term and +4°C short term once reconstituted. Reconstitute with bacteriostatic water under sterile conditions. BPC-157 and TB-500 should not be mixed in the same vial unless the research protocol specifically requires it, as this complicates concentration calculations.
Sourcing in the UK
UK Peptide Lab supplies both research-grade BPC-157 and TB-500 as lyophilised powder sourced from GMP certified manufacturers, with batch documentation available. Fast UK delivery via Royal Mail Tracked. Strictly for laboratory and in-vitro research use only.
Related Products
Disclaimer: This article is for research and educational purposes only. All information provided is not intended as medical advice. UK Peptide Lab products are not for human consumption and are sold strictly for laboratory research use only.